Global Yeast Protein Expression Service Market – Industry Trends and Forecast to 2030

Yeast Protein Expression Service Market Analysis and Size

Increase in large-scale funding and investments in the field of protein expressions and other protein-based studies is a critical factor escalating market growth, as advancements and developments in protein expression system technologies and an increase in healthcare expenditure in some parts of the world, among other factors driving the yeast protein expression service market. The rise in the technological advancements and modernization in the healthcare devices and growth in the research and development activities in the healthcare sector will further create new opportunities for the yeast protein expression service market during the forecast period.

Data Bridge Market Research analyses that the yeast protein expression service market which was USD 0.24 billion in 2022, is expected to reach USD 0.66 billion by 2030, at a CAGR of 13.50% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Yeast Protein Expression Service Market Scope and Segmentation  

Market Definition

Yeast protein expression services are defined as the outsourcing of yeast protein expression by specialised market vendors, in which they conduct yeast protein expression on behalf of their customers and share the studies and research findings with them. Yeast can be used to express secreted and cytoplasmic proteins. The methylotrophic yeast Pichia pastoris is especially useful for producing secreted proteins, including those with disulfide bonds.

Global Yeast Protein Expression Service Market Dynamics

Drivers

• Rising use of E. coli bacteria

The market is expanding due to the large-scale production of a protein using E. coli bacteria, as E. coli is the most commonly used artificial expression host and is widely used because of its genomic and physiological sequencing system, which is responsible for simplifying the cloning procedure and making the E. coli host the most popular in the pharmaceutical industry. Furthermore, this process increases the binding strength of promoter region 7 and assists in transcription. Furthermore, eukaryotic expression is critical in the pharmaceutical and biotechnology industries. These factors boosting the market growth.

• Emerging trend of outsourcing R&D activities to CROs

The yeast protein expression service market is expected to be influenced by a drop in sales due to future patient cliffs and a decline in R&D productivity. Furthermore, several pharmaceutical companies outsource their R&D programmes to various contract research organizations. All of these factors are expected to drive the yeast protein expression service market from 2023 to 2030.

Opportunities

• Development of cell free techniques for protein expression

Cell-free protein expression is performed without the use of living cells due to consumer acceptance. This technology has a number of advantages over other protein expression methods, and as a result, it is widely used. Cell-free expression is becoming more popular due to the advantages of cell-free protein approaches, such as increased speed, the ability to express hazardous proteins, and the simplicity of amino acids from selective labelling, among other things. As a result, the novel technique has the potential to accelerate the growth of the market.

Restraints/Challenges

• High cost of protein expression

High barriers to entry of the new organization and high cost of protein expression reagents will obstruct the market's growth rate. Limited disease awareness, high product costs, poor economic conditions, and a lack of favourable insurance systems all limit the adoption of eukaryotic expression systems products in developing regions around the world.

This yeast protein expression service market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the yeast protein expression service market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Yeast Protein Expression Service Market Scope

The yeast protein expression service market is segmented on the basis of system type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

System Type

• K. Lactis Systems
• Saccharomyces Systems
• Pichia Systems
• Others

 Application

• Therapeutic
• Industrial
• Research

 End-User

• Pharmaceutical and Biotechnology Companies
• Academic Research Institutes
• CROs
• Others

Yeast Protein Expression Service Market Regional Analysis/Insights

The yeast protein expression service market is analyzed and market size insights and trends are provided by country, system type, application and end-user as referenced above.

The countries covered in the yeast protein expression service market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the yeast protein expression service market because of the presence of well-developed healthcare infrastructure and favourable reimbursement policies in the region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to rise in the advancements and developments in technologies of protein expression systems and increase in the healthcare expenditure in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The yeast protein expression service market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for yeast protein expression service market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the yeast protein expression service market. The data is available for historic period 2011-2021.

Competitive Landscape and Yeast Protein Expression Service Market Share Analysis

The yeast protein expression service market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to yeast protein expression service market.

Some of the major players operating in the yeast protein expression service market are:

• Agilent Technologies, Inc. (U.S.)
• Merck KGaA (Germany)
• Bio-Rad Laboratories, Inc. (U.S.)
• QIAGEN (Germany)
• Promega Corporation (U.S.)
• Thermo Fischer Scientific, Inc. (U.S.)
• Takara Bio Inc. (Japan)
• GenScript (U.S.)
• New England Biolabs (U.S.)
• Oxford Expression Technology (U.K.)
• LifeSensors Inc. (U.S.)
• Lonza (Switzerland)
• Proteogenix (France)
• Synthetic Genomics Inc. (U.S.)
• Peak Proteins Ltd (U.K.)
• Sino Biological Inc. (China)
• ARTES Biotechnology GmbH (Germany)

SKU-45056